Found: 3
Select item for more details and to access through your institution.
CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 3, p. 955, doi. 10.1007/s10067-018-4360-3
- By:
- Publication type:
- Article
A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1162739
- By:
- Publication type:
- Article
Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0281111
- By:
- Publication type:
- Article